Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Congcong Shang
Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors
Scientific Reports
Multidisciplinary
Bis(2,2′-Bipyridine)[1,9-Bis(diphenylphosphanyl)-1,2,3,4,6,7,8,9-Octahydropyrimido[1,2-A]pyrimidin-5-Ium]ruthenium(II) Hexafluoridophosphate Dibromide Dichloromethane Disolvate Monohydrate
Acta Crystallographica Section E Structure Reports Online
Related publications
PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer
Medicinski podmladak
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of the Toxicity Profile of PD-1 Versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Analysis of the Literature
Cancer
Cancer Research
Oncology
Pharmacoeconomic Evaluation of PD-L1 Receptor Inhibitors for the Second Line Treatment of Metastatic Non-Small Cell Lung Cancer
Medical Technologies. Assessment and Choice
Design of PD-L1 Inhibitors for Lung Cancer
Bioinformation
P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
